Generic Vermox Availability
Last updated on May 7, 2025.
Vermox is a brand name of mebendazole, approved by the FDA in the following formulation(s):
VERMOX (mebendazole - tablet, chewable;oral)
-
Manufacturer: JANSSEN PHARMS
Approved Prior to Jan 1, 1982
Strength(s): 100MG (discontinued) [RLD] -
Manufacturer: JANSSEN PHARMS
Approval date: October 19, 2016
Strength(s): 500MG (discontinued) [RLD]
All of the above formulations have been discontinued.
Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Vermox. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.
See also: Generic Drug FAQ.
More about Vermox (mebendazole)
- Vermox consumer information
- Check interactions
- Compare alternatives
- Reviews (1)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Drug class: anthelmintics
- Breastfeeding
Related treatment guides
Related/similar drugs
Albenza
Albenza is used for ascariasis, capillariasis, cutaneous larva migrans, cysticercus cellulosae ...
Alinia
Alinia is used for amebiasis, ascariasis, cryptosporidiosis, dwarf tapeworm infection, giardiasis
Ozempic
Learn about Ozempic (semaglutide) for type 2 diabetes treatment, weight management, cardiovascular ...
Emverm
Emverm is used for ascariasis, hookworm infection, pinworm infection, whipworm infection
Pinworm Medicine
Pinworm Medicine is used for ascariasis, enterobiasis, hookworm infection, moniliformis infection ...
Reese's Pinworm Medicine
Reese's Pinworm Medicine is used for ascariasis, enterobiasis, hookworm infection, moniliformis ...
Pyrantel
Pyrantel is used for ascariasis, enterobiasis, hookworm infection, moniliformis infection, pinworm ...
Nitazoxanide
Nitazoxanide is used for amebiasis, ascariasis, cryptosporidiosis, dwarf tapeworm infection, giardiasis
Albendazole
Albendazole is used for ascariasis, capillariasis, cutaneous larva migrans, cysticercus cellulosae ...
Glossary
| Term | Definition |
|---|---|
| Drug Patent | A drug patent is assigned by the U.S. Patent and Trademark Office and assigns exclusive legal right to the patent holder to protect the proprietary chemical formulation. The patent assigns exclusive legal right to the inventor or patent holder, and may include entities such as the drug brand name, trademark, product dosage form, ingredient formulation, or manufacturing process A patent usually expires 20 years from the date of filing, but can be variable based on many factors, including development of new formulations of the original chemical, and patent infringement litigation. |
| Drug Exclusivity | Exclusivity is the sole marketing rights granted by the FDA to a manufacturer upon the approval of a drug and may run simultaneously with a patent. Exclusivity periods can run from 180 days to seven years depending upon the circumstance of the exclusivity grant. |
| RLD | A Reference Listed Drug (RLD) is an approved drug product to which new generic versions are compared to show that they are bioequivalent. A drug company seeking approval to market a generic equivalent must refer to the Reference Listed Drug in its Abbreviated New Drug Application (ANDA). By designating a single reference listed drug as the standard to which all generic versions must be shown to be bioequivalent, FDA hopes to avoid possible significant variations among generic drugs and their brand name counterpart. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
